News

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...
ZUG, Switzerland, April 17, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) ("Oculis”), a global ...
Neurizon Therapeutics (ASX:NUZ) has appointed three new executives as it focuses on lifting the clinical hold for NUZ-001’s ...
Science organizations are exploring new avenues and navigating multiple obstacles as they confront the Trump administration’s ...
Madrigal Pharmaceuticals has hired a former Novartis executive to succeed its retiring founder as chief medical officer.
The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...
Dr. Lee LJ, Chief Scientific Officer of Nutrigene, breaks down everything you need to know about your baby’s IQ — from ...
Mark Esser, PhD, was appointed the inaugural chief scientific officer and head of the upcoming Paul and Diane Manning Institute of Biotechnology at Charlottesville-based University of Virginia. In his ...
David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical ...
Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced ...
By Christina Hernandez Sherwood Sports partnerships are a game changer in the American Cancer Society’s fight against cancer ...